The Ufmylation Modification of Ribosomal Protein L10 in the Development of Pancreatic Adenocarcinoma

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2023 Jun 6

PMID 37280198

Authors

Kun Wang

Siyu Chen

Yue Wu

Yang Wang

Yousheng Lu

Yanzi Sun

Yijun Chen

Affiliations

Soon will be listed here.

Abstract

Pancreatic adenocarcinoma (PAAD) is the most malignant cancer with a high mortality rate. Despite the association of ribosomal protein L10 (RPL10) with PAAD and previous reports on RPL26 ufmylation, the relationship between RPL10 ufmylation and PAAD development remains unexplored. Here, we report the dissection of ufmylating process of RPL10 and potential roles of RPL10 ufmylation in PAAD development. The ufmylation of RPL10 was confirmed in both pancreatic patient tissues and cell lines, and specific modification sites were identified and verified. Phenotypically, RPL10 ufmylation significantly increased cell proliferation and stemness, which is principally resulted from higher expression of transcription factor KLF4. Moreover, the mutagenesis of ufmylation sites in RPL10 further demonstrated the connection of RPL10 ufmylation with cell proliferation and stemness. Collectively, this study reveals that PRL10 ufmylation plays an important role to enhance the stemness of pancreatic cancer cells for PAAD development.

Citing Articles

Multifaceted roles of UFMylation in health and disease.

Wang R, Li L, Zhou J, Ran J Acta Pharmacol Sin. 2025; .

PMID: 39775503 DOI: 10.1038/s41401-024-01456-9.

Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation.

Derfi K, Vasiljevic T, Dragicevic T, Glavan T Cancer Cell Int. 2024; 24(1):412.

PMID: 39702263 PMC: 11660673. DOI: 10.1186/s12935-024-03609-6.

Ribosomal protein S3A (RPS3A), as a transcription regulator of colony-stimulating factor 1 (CSF1), promotes glioma progression through regulating the recruitment and autophagy-mediated M2 polarization of tumor-associated macrophages.

Zhang L, Wang K, Li F, Zhang L, Wu L, Tie R Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39560749 DOI: 10.1007/s00210-024-03601-x.

The emerging roles of UFMylation in the modulation of immune responses.

Liang Z, Ning R, Wang Z, Kong X, Yan Y, Cai Y Clin Transl Med. 2024; 14(9):e70019.

PMID: 39259506 PMC: 11389534. DOI: 10.1002/ctm2.70019.

Role of UFMylation in tumorigenesis and cancer immunotherapy.

Ding L, Jiang X, Li T, Wang S Front Immunol. 2024; 15:1454823.

PMID: 39247188 PMC: 11377280. DOI: 10.3389/fimmu.2024.1454823.

References

Sulima S, Kampen K, Vereecke S, Pepe D, Fancello L, Verbeeck J . Ribosomal Lesions Promote Oncogenic Mutagenesis. Cancer Res. 2018; 79(2):320-327. PMC: 7116100. DOI: 10.1158/0008-5472.CAN-18-1987. View

Ishimura R, Obata M, Kageyama S, Daniel J, Tanaka K, Komatsu M . A novel approach to assess the ubiquitin-fold modifier 1-system in cells. FEBS Lett. 2016; 591(1):196-204. DOI: 10.1002/1873-3468.12518. View

Kim M, Gallick G . Gemcitabine resistance in pancreatic cancer: picking the key players. Clin Cancer Res. 2008; 14(5):1284-5. DOI: 10.1158/1078-0432.CCR-07-2247. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Karan D, Kelly D, Rizzino A, Lin M, Batra S . Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis. 2002; 23(6):967-75. DOI: 10.1093/carcin/23.6.967. View

Mahmood J, Shukla H, Soman S, Samanta S, Singh P, Kamlapurkar S . Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment. Cancers (Basel). 2018; 10(12). PMC: 6316720. DOI: 10.3390/cancers10120469. View

Peter J, Magnussen H, DaRosa P, Millrine D, Matthews S, Lamoliatte F . A non-canonical scaffold-type E3 ligase complex mediates protein UFMylation. EMBO J. 2022; 41(21):e111015. PMC: 9627666. DOI: 10.15252/embj.2022111015. View

Wang L, Xu Y, Rogers H, Saidi L, Noguchi C, Li H . UFMylation of RPL26 links translocation-associated quality control to endoplasmic reticulum protein homeostasis. Cell Res. 2019; 30(1):5-20. PMC: 6951344. DOI: 10.1038/s41422-019-0236-6. View

Gerakis Y, Quintero M, Li H, Hetz C . The UFMylation System in Proteostasis and Beyond. Trends Cell Biol. 2019; 29(12):974-986. PMC: 6917045. DOI: 10.1016/j.tcb.2019.09.005. View

10.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

11.

Liu J, Guan D, Dong M, Yang J, Wei H, Liang Q . UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. Nat Cell Biol. 2020; 22(9):1056-1063. DOI: 10.1038/s41556-020-0559-z. View

12.

Millrine D, Cummings T, Matthews S, Peter J, Magnussen H, Lange S . Human UFSP1 is an active protease that regulates UFM1 maturation and UFMylation. Cell Rep. 2022; 40(5):111168. PMC: 9638016. DOI: 10.1016/j.celrep.2022.111168. View

13.

Ganguly K, Krishn S, Rachagani S, Jahan R, Shah A, Nallasamy P . Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. Cancer Res. 2020; 81(1):91-102. PMC: 7990052. DOI: 10.1158/0008-5472.CAN-20-1293. View

14.

Spahn C, Beckmann R, Eswar N, Penczek P, Sali A, Blobel G . Structure of the 80S ribosome from Saccharomyces cerevisiae--tRNA-ribosome and subunit-subunit interactions. Cell. 2001; 107(3):373-86. DOI: 10.1016/s0092-8674(01)00539-6. View

15.

West M, Hedges J, Chen A, Johnson A . Defining the order in which Nmd3p and Rpl10p load onto nascent 60S ribosomal subunits. Mol Cell Biol. 2005; 25(9):3802-13. PMC: 1084314. DOI: 10.1128/MCB.25.9.3802-3813.2005. View

16.

Wang Z, Gong Y, Peng B, Shi R, Fan D, Zhao H . MRE11 UFMylation promotes ATM activation. Nucleic Acids Res. 2019; 47(8):4124-4135. PMC: 6486557. DOI: 10.1093/nar/gkz110. View

17.

Simsek D, Tiu G, Flynn R, Byeon G, Leppek K, Xu A . The Mammalian Ribo-interactome Reveals Ribosome Functional Diversity and Heterogeneity. Cell. 2017; 169(6):1051-1065.e18. PMC: 5548193. DOI: 10.1016/j.cell.2017.05.022. View

18.

Girardi T, Vereecke S, Sulima S, Khan Y, Fancello L, Briggs J . The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling. Leukemia. 2017; 32(3):809-819. PMC: 5669462. DOI: 10.1038/leu.2017.225. View

19.

Shalev-Benami M, Zhang Y, Matzov D, Halfon Y, Zackay A, Rozenberg H . 2.8-Å Cryo-EM Structure of the Large Ribosomal Subunit from the Eukaryotic Parasite Leishmania. Cell Rep. 2016; 16(2):288-294. PMC: 5835689. DOI: 10.1016/j.celrep.2016.06.014. View

20.

Yoo H, Kang S, Kim J, Lee J, Seong M, Lee S . Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development. Mol Cell. 2014; 56(2):261-274. DOI: 10.1016/j.molcel.2014.08.007. View